Home › Idiopathic Hypersomnia › Florida › Miami
Idiopathic Hypersomnia clinical trials in Miami, FL
6 studies for Idiopathic Hypersomnia are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 3
- PharmDev Clinical Research Institute, LLC, Miami
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
RecruitingPhase 2/3
- Takeda Site 30, Miami
- Takeda Site 7, Miami
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Miami
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
RecruitingPhase 3
- Flourish Research Miami, Miami
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Miami, Florida, Miami
- Miami, Florida, Miami
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Miami, Florida, Miami
Idiopathic Hypersomnia trials in other cities
- Cincinnati, OH7 studies
- Charlotte, NC7 studies
- Austin, TX6 studies
- Orlando, FL6 studies
- Colorado Springs, CO5 studies
- Atlanta, GA5 studies
- Columbia, SC5 studies
- San Antonio, TX5 studies
- Sterling Heights, MI4 studies
- Columbus, OH4 studies
- Philadelphia, PA4 studies
- Brandon, FL4 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.